Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography

Best Practice and Research: Clinical Gastroenterology

Volumn 29, Issue 2, 2015, Pages 253-265

  Ringe, Kristina I ^a   Wacker, Frank ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cholangiocarcinoma; Computed tomography; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT DILATATION; CANCER DIAGNOSIS; CHOLESTASIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; KLATSKIN TUMOR; LIVER PARENCHYMA; LYMPH NODE METASTASIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; TUMOR LOCALIZATION; TUMOR RECURRENCE; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; DIAGNOSTIC USE; INTRAHEPATIC BILE DUCT; PATHOLOGY; PROCEDURES;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84929293992     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2015.02.004     Document Type: Review

References (81)

1. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, and A. Ghafoor et al. Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
2. G. Klatskin Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features Am J Med 38 1965 241 256
3. M.J. Olnes, and R. Erlich A review and update on cholangiocarcinoma Oncology 66 2004 167 179
4. Y.E. Chung, M.J. Kim, Y.N. Park, J.Y. Choi, J.Y. Pyo, and Y.C. Kim et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation Radiographics 29 2009 683 700
5. K.I. Ringe, J. Weidemann, B.P. Ringe, T.J. Weismueller, M. Galanski, and J. Lotz Advances in biliary imaging: CT and MR cholangiography Ann Gastroenterol Hepatol 1 2010
6. K. Hekimoglu, Y. Ustundag, A. Dusak, Z. Erdem, B. Karademir, and S. Aydemir et al. MRCP vs. ERCP in the evaluation of biliary pathologies: review of current literature J Dig Dis 9 2008 162 169
7. J.E. van Montfoort, B. Stieger, D.K. Meijer, H.J. Weinmann, P.J. Meier, and K.E. Fattinger Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1 J Pharmacol Exp Ther 290 1999 153 157
8. K.I. Ringe, D.B. Husarik, C.B. Sirlin, and E.M. Merkle Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver AJR Am J Roentgenol 195 2010 13 28
9. K.I. Ringe, B.P. Ringe, H. Bektas, J.P. Opherk, A. Reichelt, and J. Lotz et al. Characterization and staging of central bile duct stenosis-evaluation of the hepatocyte specific contrast agent gadoxetate disodium Eur J Radiol 81 2012 3028 3034
10. Y. Kang, J.M. Lee, S.H. Kim, J.K. Han, and B.I. Choi Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images Radiology 264 2012 751 760
11. R. Manfredi, B. Barbaro, G. Masselli, A. Vecchioli, and P. Marano Magnetic resonance imaging of cholangiocarcinoma Semin Liver Dis 24 2004 155 164
12. H.S. Park, J.M. Lee, J.Y. Choi, M.W. Lee, H.J. Kim, and J.K. Han et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography AJR Am J Roentgenol 190 2008 396 405
13. R. Albazaz, C.N. Patel, F.U. Chowdhury, and A.F. Scarsbrook Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours Insights Imaging 4 2013 691 700
14. S. Breitenstein, C. Apestegui, and P.A. Clavien Positron emission tomography (PET) for cholangiocarcinoma HPB Oxf 10 2008 120 121
15. A.M. De Gaetano, V. Rufini, P. Castaldi, A.M. Gatto, L. Filograna, and A. Giordano et al. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors Abdom Imaging 37 2012 983 1003
16. K. Cameron, S. Golan, W. Simpson, S. Peti, S. Roayaie, and D. Labow et al. Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) Abdom Imaging 36 2011 463 471
17. C.G. Diederichs, L. Staib, J. Vogel, B. Glasbrenner, G. Glatting, and H.J. Brambs et al. Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses Pancreas 20 2000 109 116
18. A. Fritscher-Ravens, K.H. Bohuslavizki, D.C. Broering, L. Jenicke, H. Schafer, and R. Buchert et al. FDG PET in the diagnosis of hilar cholangiocarcinoma Nucl Med Commun 22 2001 1277 1285
19. Japan LCSGo The general rules for the clinical and pathological study of primary liver cancer 4th ed. 2000 Kanehara Tokyo
20. J.R. Ayuso, M. Pages, and A. Darnell Imaging bile duct tumors: staging Abdom Imaging 38 2013 1071 1081
21. Y. Asayama, K. Yoshimitsu, H. Irie, T. Tajima, A. Nishie, and M. Hirakawa et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma Radiology 238 2006 150 155
22. S. Worawattanakul, R.C. Semelka, T.C. Noone, B.F. Calvo, N.L. Kelekis, and J.T. Woosley Cholangiocarcinoma: spectrum of appearances on MR images using current techniques Magn Reson Imaging 16 1998 993 1003
23. J. Rimola, A. Forner, M. Reig, R. Vilana, C.R. de Lope, and C. Ayuso et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma Hepatology 50 2009 791 798
24. S.A. Kim, J.M. Lee, K.B. Lee, S.H. Kim, S.H. Yoon, and J.K. Han et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern-correlation with clinicopathologic findings Radiology 260 2011 148 157
25. H.T. Jeong, M.J. Kim, Y.E. Chung, J.Y. Choi, Y.N. Park, and K.W. Kim Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation AJR Am J Roentgenol 201 2013 W603 W611
26. K.I. Ringe, J. Hinrichs, E.M. Merkle, T.J. Weismuller, F. Wacker, and B.C. Meyer Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion J Magn Reson Imaging 40 2014 106 112
27. W. Marsh Rde, M. Alonzo, S. Bajaj, M. Baker, E. Elton, and T.A. Farrell et al. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology J Surg Oncol 106 2012 332 338
28. R.M. Gore, and R.P. Shelhamer Biliary tract neoplasms: diagnosis and staging Cancer Imaging 7 2007 S15 S23
29. M. Bilgin, F. Shaikh, R.C. Semelka, S.S. Bilgin, N.C. Balci, and A. Erdogan Magnetic resonance imaging of gallbladder and biliary system Top Magn Reson Imaging 20 2009 31 42
30. M.S. Park, T.K. Kim, K.W. Kim, S.W. Park, J.K. Lee, and J.S. Kim et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP Radiology 233 2004 234 240
31. T. Patel Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States Hepatology 33 2001 1353 1357
32. H. Bismuth, R. Nakache, and T. Diamond Management strategies in resection for hilar cholangiocarcinoma Ann Surg 215 1992 31 38
33. C.D. Anderson, M.H. Rice, C.W. Pinson, W.C. Chapman, R.S. Chari, and D. Delbeke Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma J Gastrointest Surg 8 2004 90 97
34. Y.J. Kim, M. Yun, W.J. Lee, K.S. Kim, and J.D. Lee Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma Eur J Nucl Med Mol Imaging 30 2003 1467 1472
35. E.K. Choi, Ie R. Yoo, S.H. Kim, J.H. O, W.H. Choi, and S.J. Na et al. The clinical value of dual-time point 18F-FDG PET/CT for differentiating extrahepatic cholangiocarcinoma from benign disease Clin Nucl Med 38 2013 e106 111
36. K. Alkhawaldeh, S. Faltten, H.J. Biersack, and S. Ezziddin The value of F-18 FDG PET in patients with primary sclerosing cholangitis and cholangiocarcinoma using visual and semiquantitative analysis Clin Nucl Med 36 2011 879 883
37. G.M. Nesbit, C.D. Johnson, E.M. James, R.L. MacCarty, D.M. Nagorney, and C.E. Bender Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography AJR Am J Roentgenol 151 1988 933 938
38. J.Y. Choi, M.J. Kim, J.M. Lee, K.W. Kim, J.Y. Lee, and J.K. Han et al. Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography AJR Am J Roentgenol 191 2008 1448 1457
39. C. Valls, A. Guma, I. Puig, A. Sanchez, E. Andia, and T. Serrano et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation Abdom Imaging 25 2000 490 496
40. M. Tillich, H.J. Mischinger, K.H. Preisegger, H. Rabl, and D.H. Szolar Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma AJR Am J Roentgenol 171 1998 651 658
41. H.Y. Lee, S.H. Kim, J.M. Lee, S.W. Kim, J.Y. Jang, and J.K. Han et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria Radiology 239 2006 113 121
42. H.W. Chen, A.Z. Pan, Z.J. Zhen, S.Y. Su, J.H. Wang, and S.C. Yu et al. Preoperative evaluation of resectability of Klatskin tumor with 16-MDCT angiography and cholangiography AJR Am J Roentgenol 186 2006 1580 1586
43. J. Halavaara, J. Breuer, C. Ayuso, T. Balzer, M.F. Bellin, and L. Blomqvist et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT-a multicenter trial J Comput Assist Tomogr 30 2006 345 354
44. R. Hammerstingl, A. Huppertz, J. Breuer, T. Balzer, A. Blakeborough, and R. Carter et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions Eur Radiol 18 2008 457 467
45. X.R. Yu, W.Y. Huang, B.Y. Zhang, H.Q. Li, and D.Y. Geng Differentiation of infiltrative cholangiocarcinoma from benign common bile duct stricture using three-dimensional dynamic contrast-enhanced MRI with MRCP Clin Radiol 69 2014 567 573
46. L. Guibaud, P.M. Bret, C. Reinhold, M. Atri, and A.N. Barkun Bile duct obstruction and choledocholithiasis: diagnosis with MR cholangiography Radiology 197 1995 109 115
47. T.S. Yeh, Y.Y. Jan, J.H. Tseng, C.T. Chiu, T.C. Chen, and T.L. Hwang et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings Am J Gastroenterol 95 2000 432 440
48. N.K. Lee, S. Kim, J.W. Lee, S.H. Lee, D.H. Kang, and G.H. Kim et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications Radiographics 29 2009 1707 1724
49. H. Petrowsky, P. Wildbrett, D.B. Husarik, T.F. Hany, S. Tam, and W. Jochum et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma J Hepatol 45 2006 43 50
50. C.U. Corvera, L.H. Blumgart, T. Akhurst, R.P. DeMatteo, M. D'Angelica, and Y. Fong et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer J Am Coll Surg 206 2008 57 65
51. H. Jadvar, R.W. Henderson, and P.S. Conti [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma J Comput Assist Tomogr 31 2007 223 228
52. T. Okabayashi, J. Yamamoto, T. Kosuge, K. Shimada, S. Yamasaki, and T. Takayama et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables Cancer 92 2001 2374 2383
53. M. Unno, T. Okumoto, Y. Katayose, T. Rikiyama, A. Sato, and F. Motoi et al. Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography J Hepatobiliary Pancreat Surg 14 2007 434 440
54. M.S. Park, D.K. Lee, M.J. Kim, W.J. Lee, D.S. Yoon, and S.J. Lee et al. Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma J Comput Assist Tomogr 30 2006 362 367
55. V. Vilgrain Staging cholangiocarcinoma by imaging studies HPB Oxf 10 2008 106 109
56. R. Kluge, F. Schmidt, K. Caca, H. Barthel, S. Hesse, and P. Georgi et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer Hepatology 33 2001 1029 1035
57. T. Kato, E. Tsukamoto, Y. Kuge, C. Katoh, T. Nambu, and A. Nobuta et al. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer Eur J Nucl Med Mol Imaging 29 2002 1047 1054
58. K. Khalili, U. Metser, and S.R. Wilson Hilar biliary obstruction: preliminary results with Levovist-enhanced sonography AJR Am J Roentgenol 180 2003 687 693
59. H. Shimada, S. Niimoto, A. Matsuba, G. Nakagawara, M. Kobayashi, and S. Tsuchiya The infiltration of bile duct carcinoma along the bile duct wall Int Surg 73 1988 87 90
60. J.H. Cha, J.K. Han, T.K. Kim, A.Y. Kim, S.J. Park, and B.I. Choi et al. Preoperative evaluation of Klatskin tumor: accuracy of spiral CT in determining vascular invasion as a sign of unresectability Abdom Imaging 25 2000 500 507
61. T.A. Aloia, C. Charnsangavej, S. Faria, D. Ribero, E.K. Abdalla, and J.N. Vauthey et al. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma Am J Surg 193 2007 702 706
62. I. Endo, H. Shimada, M. Sugita, Y. Fujii, D. Morioka, and K. Takeda et al. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma Surgery 142 2007 666 675
63. Y. Zhang, M. Uchida, T. Abe, H. Nishimura, N. Hayabuchi, and Y. Nakashima Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI J Comput Assist Tomogr 23 1999 670 677
64. R. Manfredi, G. Masselli, G. Maresca, M.G. Brizi, A. Vecchioli, and P. Marano MR imaging and MRCP of hilar cholangiocarcinoma Abdom Imaging 28 2003 319 325
65. E.S. Cho, M.S. Park, J.S. Yu, M.J. Kim, and K.W. Kim Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography J Comput Assist Tomogr 31 2007 72 78
66. S.S. Lee, M.H. Kim, S.K. Lee, T.K. Kim, D.W. Seo, and J.S. Park et al. MR cholangiography versus cholangioscopy for evaluation of longitudinal extension of hilar cholangiocarcinoma Gastrointest Endosc 56 2002 25 32
67. G. Masselli, and G. Gualdi Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning Abdom Imaging 33 2008 444 451
68. J. Bridgewater, P.R. Galle, S.A. Khan, J.M. Llovet, J.W. Park, and T. Patel et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma J Hepatol 60 2014 1268 1289
69. J.E. Kim, J.M. Lee, S.H. Kim, J.H. Baek, S.K. Moon, and I.S. Yu et al. Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography Radiology 257 2010 364 372
70. C.J. Zech, S.O. Schoenberg, M. Reiser, and T. Helmberger Cross-sectional imaging of biliary tumors: current clinical status and future developments Eur Radiol 14 2004 1174 1187
71. Services AH Cholangiocarcinoma and gallbladder cancer Version 3 ed. 2013 Clinical Practice Guideline GI-010
72. D. Alvaro, R. Cannizzaro, R. Labianca, F. Valvo, and F. Farinati Cholangiocarcinoma: a position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO) Dig Liver Dis 42 2010 831 838
73. S.A. Khan, B.R. Davidson, R.D. Goldin, N. Heaton, J. Karani, and S.P. Pereira et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update Gut 61 2012 1657 1669
74. Y.B. Vergel, J. Chilcott, E. Kaltenthaler, S. Walters, A. Blakeborough, and S. Thomas Economic evaluation of MR cholangiopancreatography compared to diagnostic ERCP for the investigation of biliary tree obstruction Int J Surg 4 2006 12 19
75. B. Ariff, C.R. Lloyd, S. Khan, M. Shariff, A.V. Thillainayagam, and D.S. Bansi et al. Imaging of liver cancer World J Gastroenterol 15 2009 1289 1300
76. F. Maccioni, M. Martinelli, N. Al Ansari, A. Kagarmanova, V. De Marco, and M. Zippi et al. Magnetic resonance cholangiography: past, present and future: a review Eur Rev Med Pharmacol Sci 14 2010 721 725
77. J.A. Marrero, J. Ahn, K. Rajender Reddy Americal College of G ACG clinical guideline: the diagnosis and management of focal liver lesions Am J Gastroenterol 109 2014 1328 1347
78. B.Y. Lan, S.A. Kwee, and L.L. Wong Positron emission tomography in hepatobiliary and pancreatic malignancies: a review Am J Surg 204 2012 232 241
79. J.Y. Kim, M.H. Kim, T.Y. Lee, C.Y. Hwang, J.S. Kim, and S.C. Yun et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging Am J Gastroenterol 103 2008 1145 1151
80. B.E. Van Beers Diagnosis of cholangiocarcinoma HPB Oxf 10 2008 87 93
81. G. Garcea, S.L. Ong, and G.J. Maddern The current role of PET-CT in the characterization of hepatobiliary malignancies HPB Oxf 11 2009 4 17